TopNewsOn

Results for “prostate cancer”

Lilly Buying Spree Surpasses $32B

Bloomberg’s Madison Muller joins Dani Burger on “Bloomberg Deals.”  Eli Lilly agreed to buy closely held Calytrix Bio in a deal that could be worth up to $1.5 billion, the latest in the drugmaker’s $32 billion wave of acquisitions in 2026 as it builds out its cancer and immunology businesses. (Source: Bloomberg)

Bloomberg · Nov 18
Lilly Pushes Buying Spree Beyond $32B With Calytrix Deal

Eli Lilly & Co. agreed to buy closely held Calytrix Bio Inc. in a deal that could be worth up to $1.5 billion, the latest in the drugmaker’s $32 billion wave of acquisitions in 2026 as it builds out its cancer and immunology businesses. Sam Fazeli, Bloomberg Intelligence, Director of Research for Global Industries and Senior Pharmaceuticals Analyst, discusses the biotech sector, how AI is playing a role in new developments and the importance of M&A through deals like that of Eli Lilly and Calytrix Bio. (Source: Bloomberg)

Bloomberg · Nov 16
William and Kate Begin India Tour With Cricket and Climate

Britain’s Prince William and Kate Middleton began a three-day visit to India with a game of street cricket in Mumbai, the Princes of Wales’ most prominent overseas engagement since undergoing cancer treatment in 2024.

Bloomberg · Nov 16